https://pharmadog.xyz/news/173073 pharmadog en 2026-08-01T10:00:38.000Z Alnylam’s stock continues to fall as weekly roundup highlights Q2 earnings across biopharma https://pharmadog.xyz/news/171175 pharmadog en 2026-07-31T19:55:00.000Z Lidl US expands recall of Eridanous shortbread cookies over undeclared wheat, soy, milk, egg and coconut allergens https://pharmadog.xyz/news/169893 pharmadog en 2026-07-31T18:42:00.000Z Capricor CEO hints at possible lawsuit after FDA panel rejects Duchenne cardiomyopathy therapy https://pharmadog.xyz/news/169732 pharmadog en 2026-07-31T18:22:56.000Z AbbVie says Skyrizi maintains strong sales momentum as competition rises https://pharmadog.xyz/news/169573 pharmadog en 2026-07-31T17:22:21.000Z Pharma groups support revised 340B rebate pilot that permits limited rebate denials https://pharmadog.xyz/news/169489 pharmadog en 2026-07-31T17:02:27.000Z Trump administration revises 340B rebate pilot, sparking hospital backlash https://pharmadog.xyz/news/169337 pharmadog en 2026-07-31T16:36:25.000Z Moderna delays norovirus vaccine readout, cites insufficient infections https://pharmadog.xyz/news/169361 pharmadog en 2026-07-31T16:28:44.000Z Eli Lilly and Resilience commit $750 million to expand U.S. KwikPen device capacity for diabetes and obesity treatments https://pharmadog.xyz/news/169253 pharmadog en 2026-07-31T16:11:00.000Z Novo Nordisk's heart drug ziltivekimab fails Phase 3 trial, raising doubts on inflammation-targeted therapies https://pharmadog.xyz/news/169169 pharmadog en 2026-07-31T15:35:15.000Z Novo Nordisk's late-stage anti-inflammatory heart drug fails Phase 3 trial https://pharmadog.xyz/news/169213 pharmadog en 2026-07-31T15:29:20.000Z AbbVie shares slip 4% as Q2 immunology earnings beat falls short of lofty expectations https://pharmadog.xyz/news/169214 pharmadog en 2026-07-31T15:24:07.000Z Novo Nordisk’s IL-6 drug ziltivekimab misses Phase 3 cardiovascular endpoint, shares drop 9% https://pharmadog.xyz/news/169215 pharmadog en 2026-07-31T15:19:14.000Z Moderna sticks to 10% revenue growth goal despite Phase 3 norovirus vaccine miss https://pharmadog.xyz/news/169105 pharmadog en 2026-07-31T15:06:47.000Z Sanofi CEO pledges to rebuild trust and expand partnership with Regeneron https://pharmadog.xyz/news/168958 pharmadog en 2026-07-31T14:59:38.000Z Ratio Therapeutics secures $70M Series C for radiopharma trials as Vogenx eyes $67M IPO